Description
BLOOD PRODUCTS AND SERVICES
First action · last action
2009-10-01 · 2010-04-27
Transactions
3
First transaction's obligation
$420,000
Base + all options value (sum of deltas)
$358,936
Extent competed
NON-COMPETITIVE DELIVERY ORDER
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V600PC0279
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-10-01+$420,000= $420,000
- Mod 12010-04-02-$52,000= $368,000
- Mod 22010-04-27-$9,064= $358,936
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-10-01 | +$420,000 | $420,000 | BLOOD PRODUCTS AND SERVICES |
| Mod 1· FUNDING ONLY ACTION | 2010-04-02 | −$52,000 | $368,000 | BLOOD PRODUCTS AND SERVICES |
| Mod 2· FUNDING ONLY ACTION | 2010-04-27 | −$9,064 | $358,936 | BLOOD PRODUCTS AND SERVICES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI M9V6X54L11X7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26221N0635 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $1,052,627 | FY2021 |
| 36C26221N0633 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $670,737 | FY2021 |
| 36C26221N0636 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $718,186 | FY2021 |
| 36C26221N0535 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $1,131,016 | FY2021 |
| 36C26221N0114 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $22,807 | FY2021 |
| 36C26220N1051 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $113,697 | FY2020 |
Other recipients under 6506 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA600C05109 | AMERICAN NATIONAL RED CROSS, THE | 262-NETWORK CONTRACT OFFICE 22 | $412,084 | FY2010 |
| VA600C05063 | CHARLES RIVER LABORATORIES CELL SOLUTIONS, INC. | 262-NETWORK CONTRACT OFFICE 22 | $200,000 | FY2010 |
| VA691C05062 | CHARLES RIVER LABORATORIES CELL SOLUTIONS, INC. | 262-NETWORK CONTRACT OFFICE 22 | $174,055 | FY2010 |
| VA600C90295 | AMERICAN NATIONAL RED CROSS, THE | 262-NETWORK CONTRACT OFFICE 22 | $796,092 | FY2009 |
| VA664C90308 | AMERICAN NATIONAL RED CROSS, THE | 262-NETWORK CONTRACT OFFICE 22 | $170,334 | FY2009 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA691C05061_3600_V600PC0279_3600 · retrieved 2026-09-26.